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CENTRAL HYPOTHESIS:
• Exposure to the human spaceflight 
environment causes stresses (i.e. “spaceflight 
syndrome”) which can lead to increased 
antibiotic resistance in bacterial 
opportunistic pathogens.
INVESTIGATION
• Two harmless surrogates of opportunistic pathogens (Bacillus 
subtilis and Staphylococcus epidermidis) will be cultured in 
microgravity on ISS for 24 +/- 4 hours, frozen, and returned to 
Earth.
• Global stress responses will be measured in comparison to 
ground controls using Whole Transcriptome Shotgun 
Sequencing (a.k.a. “RNA-Seq”).
• The spectrum of antibiotic resistance from flight samples and 
ground controls will be compared using the Omnilog
phenotype microarray system containing a large collection of 
antibiotics. 
• The rate of spontaneous mutation to resistance to the 
antibiotic Rifampicin (RFM) will be measured and compared to 
ground controls.
GOALS AND OBJECTIVES
• Characterize changes in the transcriptomes of 
bacteria exposed to human spaceflight 
stresses, esp. microgravity, focusing on global 
stress responses.
• Compare the extent and levels of resistance 
to various antibiotics resulting from 
spaceflight compared to ground controls.
• Compare the mutation rates of bacteria 
grown in space vs. ground controls. 
MEASUREMENT APPROACH
• Total RNA will be isolated from flight and ground-control 
cultures and their global transcriptomes compared using 
RNA-Seq. Genes significantly up- or down-regulated will 
be identified and further investigated for their stress 
relevance. 
• Upon return, cultures will be inoculated immediately into 
96-well Omnilog antibiotic plates (PM-11C, 12B, 13B) and 
assayed for the level of resistance to a battery of 
antibiotics, relative to ground control cultures.
• Cells returned from ISS will be plated for (i) total viable 
cells and (ii) RFM-resistant mutants. Mutation frequencies 
will be computed and compared relative to ground 
controls. Mutations will be identified by nucleotide 
sequencing.
IMPORTANCE AND REASON FOR ISS
• Prior evidence that astronaut immune function 
deteriorates during prolonged spaceflight.
• Prior evidence suggesting virulence and antibiotic 
resistance of some (but not all) bacteria increases 
during spaceflight.
• Thus, development of multiple antibiotic resistance in 
opportunistic pathogens is of importance to astronaut 
health.
• Prior evidence that the bacterial “spaceflight 
syndrome” appears to be organism-specific, and no 
fundamental underlying mechanism has yet emerged.
EXPECTED RESULTS
• If the Central Hypothesis is supported:
– Transcription of global stress response genes will 
be up-regulated significantly in ISS-grown 
samples compared to ground control samples.
– ISS-grown cells will exhibit resistance to a greater 
number of antibiotics, and/or to higher 
concentrations, than ground-control cells.
– Mutation frequencies to RFM resistance will be 
significantly higher in the ISS-grown cultures 
than the ground control cultures.
HOW RESULTS WILL ADVANCE THE FIELD
• Little is currently known at the molecular level 
about the global cellular stress responses of 
microbes in the human space flight environment 
and how they impact pathogenicity and 
antibiotic resistance.
• This project will enhance our knowledge of how 
potentially harmful microbes respond and adapt 
to the spaceflight environment.
• Knowledge gained from the project will 
ultimately benefit astronaut health during long-
term missions.
EARTH BENEFITS / SPIN-OFF 
APPLICATIONS
• Development and dispersal of multiply-resistant 
pathogenic bacteria is a chronic problem in 
clinical settings.
• Clinical settings in some ways mirror the human 
spaceflight environment; several people with 
compromised immune systems are housed in 
confined quarters for extended periods of time.
• Understanding how antibiotic resistance 
develops in space could lead to better methods 
for combating hospital-acquired infections.
